Drugs / Levosert
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01695902 | Dec 2007 → Jan 2010 | — | Uteron Pharma S.A. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Levosert | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01695902 ↗ |
| Modality | Other / unclassified | “Levosert is a LNG-releasing Intrauterine Delivery System (IUS)” NCT01695902 ↗ |
| Route | Other | “Intrauterine Delivery System (IUS)” NCT01695902 ↗ |